FRLI - Frelii, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0722
-0.0278 (-27.80%)
At close: 3:31PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.1000
Open0.1000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0722 - 0.1000
52 Week Range0.0200 - 1.7500
Volume6,419
Avg. Volume11,323
Market Cap3.86M
Beta (5Y Monthly)-4.48
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
All
News
Press Releases
  • ACCESSWIRE

    Frelii, Inc. Retains Public Relations Firm Consultant Horizon, Inc.

    LEHI, UT / ACCESSWIRE / May 18, 2020 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or "the Company") today announced that it has retained public relations firm Consultant Horizon, Inc. Consultant ...

  • ACCESSWIRE

    Frelii Provides Update on GATC Canna Revenue Sharing Agreement

    Multiple acquisitions to drive significant growth of customer base LEHI, UT / ACCESSWIRE / February 14, 2020 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology ...

  • ACCESSWIRE

    Frelii Announces International License and Profit Sharing Agreement

    Under the terms of the Agreement, Genecor AI Inc., a Canadian Company, has acquired the International rights (excluding the USA), to Frelii's patent pending AI, Navii for $750,000 payable in installments over 3 months. Through its network of medical professionals, Genecor AI will market Frelii's DNA technology in Canadian market, with plans to expand to other jurisdictions.

  • ACCESSWIRE

    Frelii Announces Master License Agreement with Systemic Formulations

    LEHI, UTAH / ACCESSWIRE / November 12, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing artificial intelligence technology, announced today it has signed a Master License Agreement ("Agreement) with Systemic Formulations Inc. ("Customer"). "We believe the efficacy of our genome discovery artificial intelligence, Navii, has been further validated today, as trusted leading nutraceutical company Systemic Formulations has begun selling DNA kits to its network of healthcare practitioners using Navii to provide market leading analysis," stated Frelii CEO, Ian Jenkins.

  • ACCESSWIRE

    Frelii Announces Revenue Sharing Agreement with True DNA Story

    LEHI, UT / ACCESSWIRE / October 31, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or "the Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing ...

  • ACCESSWIRE

    Frelii Announces Shareholder Update

    LEHI, UT / ACCESSWIRE / October 30, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or "the Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing artificial intelligence technology, announced today an update to shareholders regarding technology and marketing advancements. Frelii's CEO, Ian Jenkins stated, "Over the past year, through the diligence of our development team, led by respected industry leader Jayson Uffens, the Company has successfully navigated a variety of challenges, resulting in critical enhancements to our technology offering. The Company utilizes artificial intelligence and whole genome analysis to increase patient outcomes and reduce direct costs.

  • OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May
    PR Newswire

    OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May

    NEW YORK , June 5, 2019 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective ...